Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Cogle

Showing results (101-110 of 137) with videos related to

Pageof 14
Sort By:
Circulation Research|May 12, 2017
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow FunctionMahan Shahrivari, Elizabeth Wise, Micheline Resende, et al.
Leukemia Research|January 16, 2019
Predicting response to BET inhibitors using computational modeling: A BEAT AML project studyLeylah M Drusbosky, Robinson Vidva, Saji Gera, et al.
Leukemia Research|April 23, 2019
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysisBrett Stevens, Amanda Winters, Jonathan A Gutman, et al.
British Journal of Haematology|April 3, 2020
Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromesChristopher R Cogle, Bradley Collins, Daniel Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell TransplantationJeff K Davies, Lisa L Brennan, John R Wingard, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Leukemia Research|July 13, 2019
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemiaVindhya Vijay, Regan Miller, Gau Shoua Vue, et al.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Leukemia Research|January 15, 2019
Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomicsAnsu Kumar, Leylah M Drusbosky, Amy Meacham, et al.
International Journal of Cardiology|July 6, 2016
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in ratsDomenico G Della Rocca, Bradley J Willenberg, Yanfei Qi, et al.
Pageof 14

Showing results (101-110 of 137) with videos related to

Sort By:
Pageof 14
Circulation Research|May 12, 2017
Peripheral Blood Cytokine Levels After Acute Myocardial Infarction: IL-1β- and IL-6-Related Impairment of Bone Marrow FunctionMahan Shahrivari, Elizabeth Wise, Micheline Resende, et al.
Leukemia Research|January 16, 2019
Predicting response to BET inhibitors using computational modeling: A BEAT AML project studyLeylah M Drusbosky, Robinson Vidva, Saji Gera, et al.
Leukemia Research|April 23, 2019
Sequential azacitidine and lenalidomide for patients with relapsed and refractory acute myeloid leukemia: Clinical results and predictive modeling using computational analysisBrett Stevens, Amanda Winters, Jonathan A Gutman, et al.
British Journal of Haematology|April 3, 2020
Safety, feasibility and preliminary efficacy of single agent combretastatin A1 diphosphate (OXi4503) in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic syndromesChristopher R Cogle, Bradley Collins, Daniel Turner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2018
Infusion of Alloanergized Donor Lymphocytes after CD34-selected Haploidentical Myeloablative Hematopoietic Stem Cell TransplantationJeff K Davies, Lisa L Brennan, John R Wingard, et al.
American Heart Journal|December 6, 2011
Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationaleClaudia Zierold, Marjorie A Carlson, Udo C Obodo, et al.
Leukemia Research|July 13, 2019
Interleukin-8 blockade prevents activated endothelial cell mediated proliferation and chemoresistance of acute myeloid leukemiaVindhya Vijay, Regan Miller, Gau Shoua Vue, et al.
Blood Advances|September 16, 2022
Genome-wide CRISPR/Cas9 screen identifies etoposide response modulators associated with clinical outcomes in pediatric AMLNam H K Nguyen, Roya Rafiee, Abderrahmane Tagmount, et al.
Leukemia Research|January 15, 2019
Computational modeling of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) to identify personalized therapy using genomicsAnsu Kumar, Leylah M Drusbosky, Amy Meacham, et al.
International Journal of Cardiology|July 6, 2016
An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in ratsDomenico G Della Rocca, Bradley J Willenberg, Yanfei Qi, et al.
Pageof 14